Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Jinling Pharmaceutical Co Ltd

+ Add to Watchlist

000919:CH

14.410 CNY 0.020 0.14%

As of 22:29:44 ET on 01/28/2015.

Snapshot for Jinling Pharmaceutical Co Ltd (000919)

Open: 14.350 Day's Range: 14.260 - 14.630 Volume: 4,032,811
Previous Close: 14.430 52wk Range: 8.930 - 16.300 1-Yr Rtn: +59.42%

Stock Chart for 000919

No chart data available.
  • 000919:CH 14.390
  • 1D
  • 1M
  • 1Y
14.430
Interactive 000919 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 000919

Current P/E Ratio (ttm) 37.0437
Estimated P/E(12/2014) 34.5564
Relative P/E vs. SZASHR 0.9357
Earnings Per Share (CNY) (ttm) 0.3890
Est. EPS (CNY) (12/2014) 0.4170
Est. PEG Ratio -
Market Cap (M CNY) 7,262.64
Shares Outstanding (M) 504.00
30 Day Average Volume 6,098,225
Price/Book (mrq) 3.1803
Price/Sale (ttm) 2.6226
Dividend Indicated Gross Yield 1.11%
Cash Dividend (CNY) 0.1600
Dividend Ex-Date 06/24/2014
5 Year Dividend Growth 1.30%
Next Earnings Announcement 03/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 000919

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 000919

Jinling Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products. The Company's products include the Mailuoning injection for the treatment of arteries and veins, as well as traditional Chinese and western pharmaceutical preparations.

Shen ZhilongChairmanLi ChunminPresident
Tang WeiguoExecutive Vice PresidentYin JianbiaoVice President
More Company Profile & Key Executives for 000919

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil